Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-24

Clinical Trial Update: An Oral Amoxicillin-Clavulanate Regimen to Prevent Bacteremia Following Dental Procedures [Phase 4]

View source ↗

Summary

Phase 4 study evaluating an oral amoxicillin-clavulanate regimen to prevent bacteremia after dental procedures has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amoxicillin-clavulanate (amoxicillin-clavulanate)

Snippet

Sponsor: University of Santiago de Compostela | Conditions: Bacteraemia, Endocarditis | Phase 4 | Status: TERMINATED